1. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients. (December 2020) Authors: Cairo, Stefano; Armengol, Carolina; Maibach, Rudolf; Häberle, Beate; Becker, Kristina; Carrillo-Reixach, Juan; Guettier, Catherine; Vokuhl, Christian; Schmid, Irene; Buendia, Marie-Annick; Branchereau, Sophie; von Schweinitz, Dietrich; Kappler, Roland Journal: European journal of cancer Issue: Volume 141(2020) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. Issue 11 (1st November 2016) Authors: Beck, Alexander; Eberherr, Corinna; Hagemann, Michaela; Cairo, Stefano; Häberle, Beate; Vokuhl, Christian; von Schweinitz, Dietrich; Kappler, Roland Journal: Cancer biology & therapy Issue: Volume 17:Issue 11(2016) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges. Issue 1 (15th May 2018) Authors: Armengol, Carolina; Cairo, Stefano Journal: Hepatology Issue: Volume 68:Issue 1(2018) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. INSP-15. ITCC-P4: A sustainable platform of molecularly well-characterized PDX models of pediatric cancers for high throughputin vivo testing. (3rd June 2022) Authors: Kool, Marcel; Federico, Aniello; Surdez, Didier; Gopisetty, Apurva; Saberi-Ansari, Elnaz; Saint-Charles, Alexandra; Iddir, Yasmine; Waterfall, Joshua; Wierzbinska, Justyna; Schlicker, Andreas; Bhalsankar, Jaydutt; Mack, Norman; Schwalm, Benjamin; Böttcher, Anna-Lisa; Sill, Martin; Westermann, Fra... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling. Issue 2 (April 2017) Authors: Indersie, Emilie; Lesjean, Sarah; Hooks, Katarzyna B.; Sagliocco, Francis; Ernault, Tony; Cairo, Stefano; Merched‐Sauvage, Maria; Rullier, Anne; Le Bail, Brigitte; Taque, Sophie; Grotzer, Michael; Branchereau, Sophie; Guettier, Catherine; Fabre, Monique; Brugières, Laurence; Hagedorn, Martin; Bue... Journal: Hepatology communications Issue: Volume 1:Issue 2(2017) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MiR‐492 regulates metastatic properties of hepatoblastoma via CD44. (25th January 2018) Authors: von Frowein, Julia; Hauck, Stefanie M.; Kappler, Roland; Pagel, Philipp; Fleischmann, Katrin K.; Magg, Thomas; Cairo, Stefano; Roscher, Adelbert; von Schweinitz, Dietrich; Schmid, Irene Journal: Liver international Issue: Volume 38:Number 7(2018) Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Molecular classification of hepatoblastoma and prognostic value of the HB 16‐gene signature. Issue 4 (26th August 2017) Authors: Buendia, Marie‐Annick; Armengol, Carolina; Cairo, Stefano Journal: Hepatology Issue: Volume 66:Issue 4(2017) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗